Non-Alcoholic Fatty Liver Disease, How Do You Treat It?

Non-alcoholic fatty liver disease (NAFLD) accumulates fat in the liver cells due to non-alcohol-related causes. It can range from mild non-alcoholic steatosis, where only a few triglycerides are stored in the cell, to non-alcoholic hepatitis or NASH that could require a transplant should it get severe enough.

The non-alcoholic fatty liver disease differs from non-alcoholic fibrosis because NAFLD can be reversed while non-alcoholic fibrosis cannot. Like non-alcoholic steatosis, NASH does not correlate with other diseases such as diabetes or heart disease and can appear even if you lead a healthy lifestyle. The only way to determine if you have a non-alcoholic fatty liver disease is through ultrasound and biopsy.

The symptoms of non-alcoholic fatty liver disease can include:

  1. Fatigue
  2. Weight loss resistance
  3. Digestive problems such as constipation or diarrhea
  4. Lack of appetite at times
  5. Nausea and vomiting (only if the liver is inflamed)  or stomach enlargement (if steatosis is present).

Since non-alcoholic fatty liver disease is an important cause of inflammation in the liver, it may increase your risk for cardiovascular events such as heart attack and stroke, leading to early death and disability. Non-alcoholic fatty liver disease should be taken seriously by those with this condition, especially because treatments can completely reverse the non-alcoholic fatty liver disease.

Non-alcoholic fatty liver disease is the most common hepatic disorder in Western countries, with non-alcoholic steatosis alone being found in up to 80% of the population at one point in their life. In contrast, non-alcoholic fatty liver disease is present in 30%-40% of men and 20%-25% of women. Furthermore, non-alcoholic fatty liver disease becomes more prevalent with age because more than 65% of adults over 65 have non-alcoholic fatty liver disease or non-alcoholic steatosis, NASH, or non-alcoholic hepatitis. Hence, if you are over 60, get yourself tested immediately for this condition. If the non-alcoholic fatty liver disease goes untreated, it can lead to cirrhosis, but non-alcoholic steatohepatitis (NASH) can be reversed; non-alcoholic steatosis cannot because non-alcoholic fatty liver disease is not as severe as non-alcoholic steatosis. It’s also important to note that non-alcoholic fatty liver disease may also lead to non-alcoholic hepatitis, non-alcoholic fibrosis, and non-alcoholic cirrhosis, so if your doctor tells you to have NAFLD or non-alcoholic steatohepatitis (NASH), don’t forget to question them on this matter until you get a clear answer.

The only way to determine if you have a non-alcoholic fatty liver disease is through ultrasound and biopsy of the liver. If there are no symptoms present, then treatment of what seems like NAFLD will not be necessary. Still, it would be a good idea to get tested so non-alcoholic fatty liver disease/NASH doesn’t develop into non-alcoholic steatohepatitis or non-alcoholic fibrosis.

The best way to prevent non-alcoholic steatosis is to stop drinking alcohol, maintain a healthy weight and diet. Since the non-alcoholic fatty liver disease is not correlated with other diseases such as diabetes or heart disease, no known risk factors can predict who will get non-alcoholic fatty liver disease. Still, it would be best for those who have a non-alcoholic fatty liver disease if they never got obese or overweight because this increases the risk of developing non-alcoholic fatty liver disease.

There is more than one treatment option available for non-alcoholic fatty liver disease / non-alcoholic steatohepatitis (NASH) non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NASH) is an important cause of inflammation in the liver, it may increase your risk for cardiovascular events such as heart attack and stroke, leading to early death and disability. NASH can be treated through weight loss, dietary changes, along with medication

Studies on non-alcoholic fatty liver disease patients who lost at least 20 pounds saw significant improvements in non-alcoholic fatty liver disease severity. In contrast, patients that lost at least 10 pounds noticed less inflammation in their livers. Patients that were non-obese but still overweight had the most improvement when they engaged in exercise because this helped them lose 5% of their body weight.

If non-alcoholic steatohepatitis (NASH) non-alcoholic fatty liver disease goes untreated, it may lead to non-alcoholic hepatitis, non-alcoholic fibrosis, and non-alcoholic cirrhosis. Non-alcoholic fatty liver disease is more common in men than women, but the severity of non-alcoholic fatty liver disease is greater in women. There are many more symptoms for non-alcoholic fatty liver disease and nonalcoholic steatohepatitis (NASH) than prevention or risk factors. Most often, you will go undiagnosed with non-alcoholic fatty liver disease because there are no symptoms present most of the time.

Skip to content